![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
Legacy Pharmaceuticals Switzerland Gmbh Birsfelden Ch, based in Switzerland, is a pharmaceutical company.
One of their significant offerings is Protein-free dialysate of calf blood, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2002-053 - Rev 01
This TSE Type CEP, issued on January 07, 2009, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.